Moreover, in non-diabetic patients with amnestic MCI co-occurring with overweight or obesity, metformin appeared to ameliorate systemic inflammation lowering CRP levels and a partial improvement in recall memory (Luchsinger et al., 2016). Here, CRP is linked to obesity due to melanocortin 4 receptor deficiency.